Bio-Rad Labs (BIO) Misses Q3 EPS by 18c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $296.86 -0.08%
Revenue Growth %: -4.3%
Financial Fact:
Cost of goods sold: 236.55M
Today's EPS Names:
CRMT, More
Revenue Growth %: -4.3%
Financial Fact:
Cost of goods sold: 236.55M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $2.60, $0.18 worse than the analyst estimate of $2.78. Revenue for the quarter came in at $680.8 million versus the consensus estimate of $679.94 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform
- Six Flags names Mark Pauls as chief operating officer
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
